Platform Presentations of Selected HemePath Abstracts

Program Committee Moderator(s)

• 

  Joanna Conant, MD (she/her/hers)

  Pathologist
  Pathology and Laboratory Medicine
  ~
  Burlington, Vermont, United States

Co-Moderator (Early Career)(s)

• 

  Dingani Nkosi, MBBS, PhD (he/him/his)

  Molecular Genetic Pathology Fellowship
  MD Anderson Cancer Center
  Houston, Texas, United States

Session

Description: Platform presentations of selected Hematopathology abstracts.

Session

Objectives:
- Analyze platform presentations of abstracts highlighted by the Hematopathology Subdivision leadership as particularly significant.
- Evaluate the scientific merit and significance of these selected studies through further discussion with the authors.

Presentations:

• 1:15 PM - 1:30 PM EST

  (H034) Myeloid Cell SORTing for Improved NGS Interpretation (“MySORT”): A Pilot Investigation of Cell Sorting to Distinguish Somatic and Germline Variants Detected by a Clinical Myeloid NGS Panel
  

  Poster Presenter: Joel Morales-Rosado, MD (he/him/his) – Mayo Clinic
• 1:30 PM - 1:45 PM EST

  (H028) Addition of a Targeted Gene Fusion Assay into Myeloid NGS Enables Detection of Cytogenetically Cryptic, Disease-Defining AML Gene Fusions
  

  Poster Presenter: Corey Post, MD, MS – University of Michigan
• 1:45 PM - 2:00 PM EST

  (H054) Prospective Nationwide Evaluation of Whole Genome Sequencing for Acute Myeloid Leukemia
  

  Poster Presenter: Laura W. Dillon, PhD, FACMG – Virginia Tech FBRI Cancer Research Center
• 2:00 PM - 2:15 PM EST

  (H005) Validation and Implementation of B-cell Acute Lymphoblastic Leukemia (B-ALL) Subtype Classification by RNA Sequencing (RNA-Seq) Gene Expression Profiling
  

  Poster Presenter: Ryan J. Schmidt, MD, PhD – Children's Hospital Los Angeles/Keck School of Medicine of USC